BG104958A - Стабилни състави, съдържащи левосимендан и алгинова киселина - Google Patents

Стабилни състави, съдържащи левосимендан и алгинова киселина

Info

Publication number
BG104958A
BG104958A BG104958A BG10495800A BG104958A BG 104958 A BG104958 A BG 104958A BG 104958 A BG104958 A BG 104958A BG 10495800 A BG10495800 A BG 10495800A BG 104958 A BG104958 A BG 104958A
Authority
BG
Bulgaria
Prior art keywords
levosimendan
alginic acid
stable compositions
compositions
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
BG104958A
Other languages
English (en)
Other versions
BG64766B1 (bg
Inventor
Ilkka Larma
Maarit Backman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Corp
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of BG104958A publication Critical patent/BG104958A/bg
Publication of BG64766B1 publication Critical patent/BG64766B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Изобретението се отнася до фармацевтични състави на левосимендан, включващи алгинова киселина за подобряване неговата стабилност в състава. Левосименданът се прилага при лечението на застойна сърдечна недостатъчност.
BG104958A 1998-04-23 2000-11-17 Стабилни състави, съдържащи левосимендан и алгинова киселина BG64766B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI980902A FI980902A (fi) 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia

Publications (2)

Publication Number Publication Date
BG104958A true BG104958A (bg) 2001-07-31
BG64766B1 BG64766B1 (bg) 2006-03-31

Family

ID=8551576

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104958A BG64766B1 (bg) 1998-04-23 2000-11-17 Стабилни състави, съдържащи левосимендан и алгинова киселина

Country Status (33)

Country Link
US (1) US6531458B1 (bg)
EP (1) EP1079834B1 (bg)
JP (1) JP4475809B2 (bg)
KR (1) KR100590622B1 (bg)
CN (1) CN1165309C (bg)
AT (1) ATE231395T1 (bg)
AU (1) AU756338B2 (bg)
BG (1) BG64766B1 (bg)
BR (1) BR9909867A (bg)
CA (1) CA2329232C (bg)
CZ (1) CZ290911B6 (bg)
DE (1) DE69905034T2 (bg)
DK (1) DK1079834T3 (bg)
EA (1) EA002428B1 (bg)
EE (1) EE04143B1 (bg)
ES (1) ES2191426T3 (bg)
FI (1) FI980902A (bg)
GE (1) GEP20032942B (bg)
HK (1) HK1031998A1 (bg)
HR (1) HRP20000703B1 (bg)
HU (1) HUP0105446A3 (bg)
ID (1) ID26650A (bg)
IL (2) IL138950A0 (bg)
MX (1) MXPA00010368A (bg)
NO (1) NO318575B1 (bg)
NZ (1) NZ507455A (bg)
PL (1) PL192274B1 (bg)
PT (1) PT1079834E (bg)
RS (1) RS49955B (bg)
SK (1) SK284600B6 (bg)
TR (1) TR200003101T2 (bg)
WO (1) WO1999055337A1 (bg)
ZA (1) ZA200005630B (bg)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
EP1366761A4 (en) * 2001-02-13 2004-04-21 Taisho Pharmaceutical Co Ltd GEL PREPARATIONS FOR INTERNAL USE
WO2006097570A1 (en) * 2005-03-14 2006-09-21 Orion Corporation A combination treatment for enhancing diuresis
CA3004362C (en) * 2015-11-06 2022-10-04 Carinopharm Gmbh Improved formulations of levosimendan for intravenous administration as infusion or injection and of infusion concentrate
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
NZ203684A (en) 1982-04-05 1986-06-11 Merck Sharp & Dohme Granular formulation for the stabilization of unstable drugs or food supplements
EP0123291A2 (en) 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
US4906630A (en) * 1985-11-22 1990-03-06 Rorer Pharmaceutical Corporation Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
US4716042A (en) * 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia

Also Published As

Publication number Publication date
IL138950A0 (en) 2001-11-25
FI980902A (fi) 1999-10-24
HRP20000703A2 (en) 2001-04-30
PL192274B1 (pl) 2006-09-29
NO318575B1 (no) 2005-04-11
US6531458B1 (en) 2003-03-11
HUP0105446A3 (en) 2002-09-30
DE69905034D1 (de) 2003-02-27
BR9909867A (pt) 2000-12-19
KR100590622B1 (ko) 2006-06-19
EE200000616A (et) 2002-06-17
PT1079834E (pt) 2003-04-30
EP1079834A1 (en) 2001-03-07
JP2002512964A (ja) 2002-05-08
KR20010072577A (ko) 2001-07-31
ID26650A (id) 2001-01-25
EP1079834B1 (en) 2003-01-22
DK1079834T3 (da) 2003-04-07
FI980902A0 (fi) 1998-04-23
CN1298303A (zh) 2001-06-06
CA2329232A1 (en) 1999-11-04
ATE231395T1 (de) 2003-02-15
CZ20003779A3 (en) 2001-05-16
AU756338B2 (en) 2003-01-09
WO1999055337A1 (en) 1999-11-04
TR200003101T2 (tr) 2001-01-22
EA002428B1 (ru) 2002-04-25
NO20005312L (no) 2000-11-21
ZA200005630B (en) 2002-01-14
EA200001097A1 (ru) 2001-04-23
NO20005312D0 (no) 2000-10-20
HRP20000703B1 (en) 2009-11-30
HUP0105446A2 (hu) 2002-07-29
AU3524899A (en) 1999-11-16
RS49955B (sr) 2008-09-29
HK1031998A1 (en) 2001-07-06
ES2191426T3 (es) 2003-09-01
SK15552000A3 (sk) 2001-05-10
YU64000A (sh) 2002-12-10
CZ290911B6 (cs) 2002-11-13
SK284600B6 (sk) 2005-07-01
JP4475809B2 (ja) 2010-06-09
PL343722A1 (en) 2001-09-10
NZ507455A (en) 2002-02-01
MXPA00010368A (es) 2002-07-02
CN1165309C (zh) 2004-09-08
DE69905034T2 (de) 2003-09-04
BG64766B1 (bg) 2006-03-31
IL138950A (en) 2006-08-20
CA2329232C (en) 2007-10-30
EE04143B1 (et) 2003-10-15
GEP20032942B (en) 2003-04-25

Similar Documents

Publication Publication Date Title
BG102425A (bg) (метилсулфонил)фенил-2-(5н)-фуранони като инхибитори на циклооксигеназа-2
BG103190A (bg) Заместени пиримидинови производни и тяхната фармацевтична употреба
ZA988158B (en) Sulfinic acid derivatives and their preparation and use
MY116272A (en) Immunity enhancing lactic acid bacteria
BG103793A (bg) Комбинирана терапия с използване на бензотиапини,инхибиращи илеалния жлъчно киселинен транспорт и на нмg со-а редуктазни инхибитори
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
AU3227700A (en) Skin sanitizing compositions
HK1021539A1 (en) Androstene derivatives.
PL314187A1 (en) Novel derivatives of pyrazine carboxamide, method of obtaining them and their application in pharmaceutical composition
ATE218350T1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
HK1018701A1 (en) Benzopyran derivatives having leukotriene-antagonistic action.
BG102623A (bg) Нови производни на бензоилгуанидина, методи за тяхното получаване и приложението им за производството на ле- карствени средства
BG104726A (bg) Нови производни на дихидроксихексанкарбонова киселина
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
BG102814A (bg) Нови производни на карбоксилни киселини, тяхното получаване и използване
BG104958A (bg) Стабилни състави, съдържащи левосимендан и алгинова киселина
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
FR2742048B1 (fr) Utilisation de l'alpha-cyano-beta, beta-diphenylacrylate de 2-ethylhexyle pour ameliorer la stabilite de compositions cosmetiques contenant le p-methyl-benzylidene camphre en association avec un derive de dibenzoylmethane
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
YU17999A (sh) Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu
UA10455A (uk) Склад для обробки пласта
ATE69609T1 (de) Cardiotonische imidazolylphenylpyrrol-2-one.
DE69626010D1 (de) Verwendung von tropolon derivate zur hemmung des inositmono phosphatase